OpenAI Researcher Launches AI Drug Discovery Startup Seeking $200 Million at $2 Billion Valuation
OpenAI researcher Miles Wang is leaving the company to launch a new venture centered on artificial intelligence drug discovery, according to a report by TechCrunch. The startup is in discussions to secure $200 million in funding at a $2 billion valuation.
The transaction highlights a broader shift in venture capital toward machine learning applications in life sciences. Sources provided the financial details to the reporting outlet, with a launch timeline for the research entity not yet announced.
From the sources (3 posts)
@katie_roofRT @TechCrunch: OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
@techcrunchOpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
@techmemeSources: OpenAI researcher Miles Wang is leaving the company to launch an AI drug discovery startup, and is in talks to raise $200M at a $2B valuation (@mtemkin / TechCrunch) (Visit Techmeme dot com for the link and full context!)